|

Evofosfamide Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • ImmunoGenesis1

Indications

  • Metastatic Head and Neck Squamous Cell Carcinoma1
  • Metastatic Pancreatic Cancer1
  • Metastatic Prostate Cancer1
  • Cancer1

Houston, Texas1 trial

A Study of Evofosfamide in Combination with Zalifrelimab and Balstilimab

MD Anderson Cancer Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.